These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8162600)

  • 21. Co-expression and amplification of dihydrofolate reductase cDNA and the Escherichia coli XGPRT gene in Chinese hamster ovary cells.
    Ringold G; Dieckmann B; Lee F
    J Mol Appl Genet; 1981; 1(3):165-75. PubMed ID: 6180118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential.
    Dini G; Funghini S; Witort E; Magnelli L; Fanti E; Rifkin DB; Del Rosso M
    J Cell Physiol; 2002 Oct; 193(1):64-72. PubMed ID: 12209881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal diploid human and rodent cells lack a detectable frequency of gene amplification.
    Tlsty TD
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3132-6. PubMed ID: 2326271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of genetic instability and apoptosis in the presence of oncogenic Ki-Ras.
    Chen CY; Liou J; Forman LW; Faller DV
    Cell Death Differ; 1998 Nov; 5(11):984-95. PubMed ID: 9846185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors.
    Li M; Hantzopoulos PA; Banerjee D; Zhao SC; Schweitzer BI; Gilboa E; Bertino JR
    Hum Gene Ther; 1992 Aug; 3(4):381-90. PubMed ID: 1525211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate resistance in NIH3T3 cells expressing polyoma virus oncogenes.
    Wani M; Snapka RM
    Teratog Carcinog Mutagen; 1989; 9(6):369-82. PubMed ID: 2576816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Rap 1 suppresses genomic instability of H-ras transformed mouse fibroblasts.
    Wani MA; Denko NC; Stambrook PJ
    Somat Cell Mol Genet; 1997 Mar; 23(2):123-33. PubMed ID: 9330640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.
    Chang MY; Won SJ; Liu HS
    J Cancer Res Clin Oncol; 1997; 123(2):91-9. PubMed ID: 9030247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of cytotoxicity of chemotherapeutic drugs by activated H-ras.
    Fan J; Banerjee D; Stambrook PJ; Bertino JR
    Biochem Pharmacol; 1997 Apr; 53(8):1203-9. PubMed ID: 9175726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of resistance to antifolates, a review.
    Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
    Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of methotrexate resistance in osteosarcoma.
    Guo W; Healey JH; Meyers PA; Ladanyi M; Huvos AG; Bertino JR; Gorlick R
    Clin Cancer Res; 1999 Mar; 5(3):621-7. PubMed ID: 10100715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new myeloblastic leukemia cell line with double minute chromosomes. Induction of methotrexate resistance and dihydrofolate reductase gene amplification.
    Saito H; Kishi K; Narita M; Furukawa T; Nagura E; Maekawa T; Abe T; Shibata A
    Leuk Res; 1992; 16(3):217-26. PubMed ID: 1560671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
    Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
    Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine.
    Thaithong S; Ranford-Cartwright LC; Siripoon N; Harnyuttanakorn P; Kanchanakhan NS; Seugorn A; Rungsihirunrat K; Cravo PV; Beale GH
    Exp Parasitol; 2001 Jun; 98(2):59-70. PubMed ID: 11465989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Geminin functions downstream of p53 in K-ras-induced gene amplification of dihydrofolate reductase.
    Shen L; Nishioka T; Guo J; Chen C
    Cancer Res; 2012 Dec; 72(23):6153-62. PubMed ID: 23026135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DHFR gene amplification in cultured skin fibroblasts of ataxia telangiectasia patients after methotrexate selection.
    Lücke-Huhle C; Hinrichs S; Speit G
    Carcinogenesis; 1987 Dec; 8(12):1801-6. PubMed ID: 2824082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells.
    McIvor RS; Simonsen CC
    Nucleic Acids Res; 1990 Dec; 18(23):7025-32. PubMed ID: 2263462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfection of DHFR- and DHFR+ mammalian cells using methotrexate-resistant mutants of mouse dihydrofolate reductase.
    Thillet J; Pictet R
    FEBS Lett; 1990 Sep; 269(2):450-3. PubMed ID: 2401371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug resistance and gene amplification potential regulated by transforming growth factor beta 1 gene expression.
    Huang A; Jin H; Wright JA
    Cancer Res; 1995 Apr; 55(8):1758-62. PubMed ID: 7712485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug resistance in KHT fibrosarcoma cell lines with different metastatic ability.
    Cillo C; Ling V; Hill RP
    Int J Cancer; 1989 Jan; 43(1):107-11. PubMed ID: 2910823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.